10.05.2013 • NewsBayeranimal healthBayer Teva

Bayer HealthCare Integrates Animal Health Acquisition

Bayer HealthCare is successfully integrating the recently acquired Teva Animal Health by beginning the process of introducing products to the U.S. market under the Bayer brand. This U.S. acquisition was the largest-ever for Bayer HealthCare's Animal Health Division, broadening the portfolio with complementary companion and food animal products.

The seven DVM dermatology and supplement products reintroduced to U.S. veterinarians were: ChlorhexiDerm 4% Shampoo; Free Form Liquid; Malase Flush; OtiRinse; Relief Creme Rinse; and Relief Spray. In addition, Preva Medicated Wipes were launched. Over the next 12 to 18 months, additional products from the acquisition will continue to enter the U.S. market.

In 2012, Bayer HealthCare signed an agreement to acquire the US-Animal Health business based in St. Joseph, Missouri. The acquisition reinforced the food animal franchise of Bayer HealthCare by providing a range of anti-infective solutions for livestock and introducing reproductive hormones to Bayer's product offerings. This transaction also strengthened Bayer HealthCare's companion animal franchise by expanding its portfolio with dermatological, pet wellness and nutraceutical products.

 

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.